UMN Pharma Inc. reported non-consolidated earnings results for the six months ended June 30, 2019. For the six months, net sales were JPY 50 million against JPY 53 million a year ago. Operating loss was JPY 342 million against JPY 305 million a year ago. Ordinary loss was JPY 343 million against JPY 307 million a year ago. Net loss was JPY 344 million against JPY 388 million a year ago. Net loss per basic share was JPY 22.53 against JPY 30.34 a year ago.

For the fiscal year ending December 31, 2019, the company expects net sales to JPY 100 million, operating loss to be JPY 887 million, ordinary loss to be JPY 891 million, net loss to be JPY 893 million and loss per share to be JPY 58.36.